World's Best Scientists 2026 revealed!
Patrizia Rovere-Querini

Patrizia Rovere-Querini

D-Index & Metrics

Immunology

D-Index
89
Citations
38415
World Ranking
1100
National Ranking
38

Medicine

D-Index
89
Citations
38491
World Ranking
12489
National Ranking
473

Patrizia Rovere-Querini publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Patrizia Rovere-Querini sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 334 publications — 71st percentile

71% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Patrizia Rovere-Querini D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Patrizia Rovere-Querini sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 89 D-Index — 78th percentile

78% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Patrizia Rovere-Querini is affiliated with the Vita-Salute San Raffaele University in Italy. Their academic contributions primarily focus on medical research, particularly within infectious diseases, neurology, immunology, epidemiology, and clinical psychology.

The researcher has published extensively on topics related to COVID-19. Key areas of study include the long-term effects of COVID-19, clinical research studies on COVID-19, SARS-CoV-2 and COVID-19 research, COVID-19 and mental health, systemic lupus erythematosus research, tryptophan and brain disorders, and intensive care unit cognitive disorders.

Notable papers authored or co-authored by Patrizia Rovere-Querini include:

  • Anxiety and depression in COVID-19 survivors: Role of inflammatory and clinical predictors (2020), Brain Behavior and Immunity
  • Interleukin-1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study (2020), The Lancet Rheumatology
  • Persistent psychopathology and neurocognitive impairment in COVID-19 survivors: Effect of inflammatory biomarkers at three-month follow-up (2021), Brain Behavior and Immunity
  • Microvascular COVID-19 lung vessels obstructive thromboinflammatory syndrome (MicroCLOTS): an atypical acute respiratory distress syndrome working hypothesis (2020), Critical Care and Resuscitation
  • Efficacy and safety of tocilizumab in severe COVID-19 patients: a single-centre retrospective cohort study (2020), European Journal of Internal Medicine

Frequently collaborating with other researchers, Patrizia Rovere-Querini has worked with:

  • Fabio Ciceri
  • Rebecca De Lorenzo
  • Moreno Tresoldi
  • Alberto Zangrillo
  • Giovanni Landoni

Publication venues regularly featuring their work include:

  • Scientific Reports
  • Annals of the Rheumatic Diseases
  • Andrology
  • The Journal of Clinical Endocrinology & Metabolism
  • European Neuropsychopharmacology

Their expertise encompasses a wide range of medical research areas with 438 publications broadly categorized under medicine. Subfields emphasize infectious diseases, neurology, and immunology with significant academic output related to COVID-19's clinical and psychological impacts.

Best Publications

  • Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)

    Daniel J. Klionsky;Amal Kamal Abdel-Aziz;Sara Abdelfatah;Mahmoud Abdellatif

  • Anxiety and depression in COVID-19 survivors: Role of inflammatory and clinical predictors.

    Mario Gennaro Mazza;Rebecca De Lorenzo;Caterina Conte;Sara Poletti

  • Interleukin-1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study.

    Giulio Cavalli;Giacomo De Luca;Corrado Campochiaro;Emanuel Della-Torre

  • Consensus guidelines for the detection of immunogenic cell death

    Oliver Kepp;Laura Senovilla;Ilio Vitale;Erika Vacchelli

  • HMGB1 is an endogenous immune adjuvant released by necrotic cells

    Patrizia Rovere-Querini;Annalisa Capobianco;Paola Scaffidi;Barbara Valentinis

  • Advancing the global public health agenda for NAFLD: a consensus statement.

    Jeffrey V Lazarus;Henry E Mark;Quentin M Anstee;Juan Pablo Arab

  • Release of High Mobility Group Box 1 by Dendritic Cells Controls T Cell Activation via the Receptor for Advanced Glycation End Products

    Ingrid E. Dumitriu;Paramita Baruah;Barbara Valentinis;Reinhard E. Voll

  • Induction of inflammatory and immune responses by HMGB1–nucleosome complexes: implications for the pathogenesis of SLE

    Vilma Urbonaviciute;Barbara G. Fürnrohr;Silke Meister;Luis Munoz

  • Microvascular COVID-19 lung vessels obstructive thromboinflammatory syndrome (MicroCLOTS): an atypical acute respiratory distress syndrome working hypothesis

    Fabio Ciceri;Luigi Beretta;Anna Mara Scandroglio;Sergio Colombo

  • Activated platelets present high mobility group box 1 to neutrophils, inducing autophagy and promoting the extrusion of neutrophil extracellular traps

    N. Maugeri;L. Campana;M. Gavina;C. Covino

  • Persistent psychopathology and neurocognitive impairment in COVID-19 survivors: Effect of inflammatory biomarkers at three-month follow-up.

    Mario Gennaro Mazza;Mariagrazia Palladini;Rebecca De Lorenzo;Cristiano Magnaghi

  • Macrophages are alternatively activated in patients with endometriosis and required for growth and vascularization of lesions in a mouse model of disease.

    Monica Bacci;Annalisa Capobianco;Antonella Monno;Lucia Cottone

  • HMGB1: guiding immunity from within

    Ingrid E. Dumitriu;Paramita Baruah;Angelo A. Manfredi;Marco E. Bianchi

  • To NET or not to NET:current opinions and state of the science regarding the formation of neutrophil extracellular traps

    Sebastian Boeltz;Poorya Amini;Hans Joachim Anders;Felipe Andrade

  • Efficacy and safety of tocilizumab in severe COVID-19 patients: a single-centre retrospective cohort study.

    Corrado Campochiaro;Emanuel Della-Torre;Giulio Cavalli;Giacomo De Luca

  • X-linked recessive TLR7 deficiency in ~1% of men under 60 years old with life-threatening COVID-19.

    Takaki Asano;Bertrand Boisson;Bertrand Boisson;Bertrand Boisson;Fanny Onodi;Daniela Matuozzo;Daniela Matuozzo

  • Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors.

    Marco Ripa;Laura Galli;Andrea Poli;Chiara Oltolini

  • Endometriosis, a disease of the macrophage

    Annalisa Capobianco;Patrizia Rovere-Querini

  • The secretion of HMGB1 is required for the migration of maturing dendritic cells

    Ingrid E. Dumitriu;Marco E. Bianchi;Monica Bacci;Angelo A. Manfredi

  • Polarization dictates iron handling by inflammatory and alternatively activated macrophages

    Gianfranca Corna;Lara Campana;Emanuele Pignatti;Alessandra Castiglioni

Frequent Co-Authors

Angelo A. Manfredi
Angelo A. Manfredi Vita-Salute San Raffaele University
Fabio Ciceri
Fabio Ciceri Vita-Salute San Raffaele University
Marco Bianchi
Marco Bianchi Vita-Salute San Raffaele University
Alberto Zangrillo
Alberto Zangrillo Vita-Salute San Raffaele University
Giovanni Landoni
Giovanni Landoni Vita-Salute San Raffaele University
Alberto Mantovani
Alberto Mantovani Humanitas University
Emilio Clementi
Emilio Clementi University of Milan
Angela Tincani
Angela Tincani University of Brescia
Antonella Castagna
Antonella Castagna Vita-Salute San Raffaele University
Angelo Corti
Angelo Corti Vita-Salute San Raffaele University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related healthcare degrees can open doors to diverse career opportunities. Many immunology students consider accelerated nursing paths, especially if they are transitioning from non-nursing backgrounds. Programs like accelerated bsn programs for non nurses offer a faster track to nursing licensure, which can complement immunology expertise.

Entry-level nursing roles are also accessible through lpn programs easy to get into. These programs provide foundational clinical experience relevant to immunological research and patient care, serving as stepping stones toward advanced practice.

Graduates often pursue advanced credentials such as nurse practitioner roles. Identifying what is the easiest np program helps prospective students find manageable paths to grow their clinical expertise while integrating immunology knowledge.

Specializing further, many opt for psychiatric-mental health nurse practitioner degrees. Top programs known for their support and clinical placements can be found by reviewing top pmhnp programs. Such specialization enhances career flexibility and impact in healthcare broadly.

Best Scientists Citing Patrizia Rovere-Querini

Trending Scientists

Recently Published Articles